Burning Rock Biotech (BNR) Work In Process (2020 - 2025)
Burning Rock Biotech has reported Work In Process over the past 6 years, most recently at $11.0 million for Q4 2025.
- For Q4 2025, Work In Process rose 4.27% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, up 4.27%, while the annual FY2025 figure was $11.1 million, 7.47% up from the prior year.
- Work In Process for Q4 2025 was $11.0 million at Burning Rock Biotech, up from $10.5 million in the prior quarter.
- Over five years, Work In Process peaked at $11.3 million in Q4 2023 and troughed at $8.9 million in Q4 2021.
- A 5-year average of $10.5 million and a median of $10.9 million in 2022 define the central range for Work In Process.
- Biggest five-year swings in Work In Process: skyrocketed 126.45% in 2021 and later decreased 6.93% in 2024.
- Year by year, Work In Process stood at $8.9 million in 2021, then increased by 22.55% to $10.9 million in 2022, then grew by 3.89% to $11.3 million in 2023, then dropped by 6.93% to $10.5 million in 2024, then grew by 4.27% to $11.0 million in 2025.
- Business Quant data shows Work In Process for BNR at $11.0 million in Q4 2025, $10.5 million in Q4 2024, and $11.3 million in Q4 2023.